The new edition of a concise yet thorough illustrated review of the diagnosis and treatment of many forms of psoriasis now includes the many new therapies available and in development, as well as more material on psoriasis as a systemic disease and on comorbidities. This will be of interest to all dermatologists in training and practice, as well as primary care physicians.
"The authors should be recognized for their comprehensive approach to the topic, which goes so far as to include a detailed discussion of topical agents including current therapies and those in Phase 2 and 3 animal studies. The authors pay particular attention to the practical utility of PUVA and UVB therapy (including home therapy) and carefully inform the generalist of the applicability of such treatments. A succinct explanation of the traditional therapies follows complete with tables elucidating adverse effects, drug-drug interactions and lab parameters to guide therapy. Both experts in dermatologic conditions, as well as general primary care practitioners will benefit from the information presented in Psoriasis, Second Edition. The authors have an astute command of the psoriasis domain and thus, this book is highly recommended general readers and specialists."
James S. Studdiford, Thomas Jefferson University, USA
The history of psoriasis. Epidemiology. Microscopic findings. Genetics. Immunology. Other environmental risk factors. Plaque type psoriasis: Chronic plaque, guttate, and erythrodermic phenotypes. Palmoplantar psoriasis. Generalised pustular psoriasis. Inverse psoriasis and genital disease. Nail psoriasis. Differential diagnoses of psoriasis. Genetics, immunology, and pathogenesis. Psoriatic arthritis: Clinical manifestations. Pediatric psoriasis. Cardiometabolic comorbidities. Psychiatric comorbidities. Other disease associations: Liver, gastrointestinal, respiratory, and neoplastic. Assessment and measurement of disease. Current and future topical treatments for psoriasis. Phototherapy and photochemotherapy.Traditional systemic therapies and monitoring guidelines. Current biologic therapies (including IL-17) and monitoring guidelines. Current and future oral small molecules. Biologic therapies in the pipeline. Future directions and personalized medicine. Conclusion.